BLS Pharmaceuticals Limited (ASX:BLS)

BLS Pharmaceuticals Balance Sheet

Financials in millions AUD. Fiscal year is July - June.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Cash & Equivalents	7.6	7.67	1.03	3.85	0.07	1.6
Cash & Short-Term Investments	7.6	7.67	1.03	3.85	0.07	1.6
Cash Growth	-0.86%	645.88%	-73.27%	5733.24%	-95.88%	-8.33%
Accounts Receivable	5.81	2.35	0.98	0.83	0.23	0.34
Other Receivables	0.2	0.18	0.26	0.18	0.02	0.06
Receivables	6.01	2.54	1.24	1.01	0.25	0.4
Inventory	11.73	3.61	2.14	0.99	0.08	0.37
Prepaid Expenses	3.34	0.87	0.76	0.19	0.01	0.12
Other Current Assets	-	1.06	0.42	0	0	0.02
Total Current Assets	28.69	15.74	5.59	6.04	0.4	2.51
Property, Plant & Equipment	5.52	3.37	0.82	0.09	0.04	0.09
Goodwill	-	-	-	11.57	-	-
Other Intangible Assets	0.33	-	-	-	-	0.07
Long-Term Deferred Charges	-	0.39	0.29	-	-	-
Other Long-Term Assets	0.08	0.08	-	-	-	-
Total Assets	34.63	19.58	6.7	17.69	0.45	2.68

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Accounts Payable	4.7	2.73	1.19	1.21	0.2	0.18
Accrued Expenses	1.87	1.4	0.87	0.69	0.11	0.56
Short-Term Debt	0.27	-	0.04	0.56	0.4	-
Current Portion of Long-Term Debt	0.38	0.07	-	-	-	-
Current Portion of Leases	0.56	0.4	0.18	-	-	-
Other Current Liabilities	0.94	1.81	0.62	0.23	0.1	0.01
Total Current Liabilities	10.3	6.4	2.91	2.69	0.82	0.74
Long-Term Debt	2.09	0.28	-	-	-	-
Long-Term Leases	2.06	0.79	0.49	-	-	-
Other Long-Term Liabilities	-	-	-	-	-0	-
Total Liabilities	14.45	7.47	3.4	2.69	0.81	0.74

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Common Stock	22.21	21.48	19	17.55	0.13	62.18
Retained Earnings	-3.67	-10.7	-15.6	-2.48	-0.54	-60.24
Comprehensive Income & Other	1.62	1.63	0.21	0.07	0.05	-0.06
Total Common Equity	20.17	12.41	3.61	15.14	-0.36	1.88
Minority Interest	-	-0.31	-0.31	-0.13	-	0.05
Shareholders' Equity	20.17	12.1	3.3	15.01	-0.36	1.93
Total Liabilities & Equity	34.63	19.58	6.7	17.69	0.45	2.68

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Total Debt	5.37	1.53	0.71	0.56	0.4	-
Net Cash (Debt)	2.24	6.13	0.32	3.29	-0.33	1.6
Net Cash Growth	-63.55%	1831.58%	-90.34%	-	-	-5.78%
Net Cash Per Share	0.01	0.03	0.00	0.02	-0.00	0.03
Filing Date Shares Outstanding	222.54	217.18	204.66	190.16	64.01	64.01
Total Common Shares Outstanding	222.54	216.48	204.66	190.16	64.01	64.01
Working Capital	18.39	9.34	2.68	3.35	-0.41	1.77
Book Value Per Share	0.09	0.06	0.02	0.08	-0.01	0.03
Tangible Book Value	19.84	12.41	3.61	3.57	-0.36	1.81
Tangible Book Value Per Share	0.09	0.06	0.02	0.02	-0.01	0.03
Machinery	2.95	2.19	0.38	-	0.08	0.1
Leasehold Improvements	0.85	0.61	-	-	-	0.05

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Aug 6, 2026

Data Sources Report a data error